Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

AC Immune SA

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
11.10-0.45-3.90%Vol 279 5391Y Perf -8.58%
Dec 12th, 2018 16:00
BID11.10 ASK11.23
Open11.89 Previous Close11.55
Pre-Market- After-Trading-
 - -%  - -%
Target Price
22.00 
Analyst Rating
Strong Buy 1.00
Potencial %
98.20 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     49.88
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     45.95
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)731 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
38.48 
Earnings Date
12th Nov 2018

Today's Price Range

11.0712.50

 

52wk Range

7.1617.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
33.37%
3 Months
46.57%
6 Months
17.38%
1 Year
-8.58%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACIU11.10-0.4500-3.90
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
JNJ147.100.60000.41
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
19.00
Current Ratio
19.20
Long Term Debt to Total Capital
0.00
Total Debt to Equity
0.00
Interest Coverage
-251.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-144.00
EBITDA Margin
-140.10
Pre-tax Profit Margin
-
Profit Margin
-91.82
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
3.89
PS Ratios
32.98
Price to Cash Flow
35.80
Price to Free Cash Flow
-26.40
Cash Flow Per Share
-0.44
Price to Tangible Book
3.84
Book Value per Share
2.87
Enterprise Value (in ths.)
551 254
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-21.11
Return on Assets (5Y Avg)
-
ROA last 12 Months
-19.25
Return on Capital (5Y Avg)
-
ROC last 12 Months
-21.15
Return on invested Capital Q
-9.35
Return on invested Capital Y
-20.46
Assets Turnover
0.10
Receivables Turnover
8.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
22 774
Revenue per Share
0.34
Revenue Growth 3 Years
-21.33
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.27-0.1929.63
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.2411.11Positive
12/2018 QR-0.270.00-
12/2018 FY-0.858.60Positive
12/2019 FY-0.922.13Positive
Next Report Date-
Estimated EPS Next Report-0.26
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume279 539
Shares Outstanding (in ths.)65 860
Trades Count1 573
Dollar Volume3 038 854
Avg. Volume116 524
Avg. Weekly Volume113 913
Avg. Monthly Volume105 818
Avg. Quarterly Volume127 095

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

43%57%

Bearish Bullish

62%38%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News